You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 204 No. 3, April 15, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Live Attenuated Rubella Virus Vaccines Prepared in Duck Embryo Cell Culture

I. Development and Clinical Testing

Eugene B. Buynak, PhD; Maurice R. Hilleman, PhD, DSc; Robert E. Weibel, MD; Joseph Stokes, Jr., MD, DSc

JAMA. 1968;204(3):195-200.


Abstract

Merck strain rubella virus and Meyer-Parkman monkey kidney attenuated HPV-77 virus were prepared at various levels of attenuation for investigative use in humans and animals. The vaccines were produced in duck embryo cell culture and represented a spectrum which ranged from underattenuation, causing communicable mild rubella, to overattenuation with apparent nonexcretion and inadequate immunization. Merck strain rubella virus at attenuation level B, or possibly C, and Meyer-Parkman HPV-77 virus in fifth passage in duck embryo cell culture appear to present the attributes of an effective noncontagious vaccine. The antibody, produced in children after administration of level C vaccine, persisted undiminished for at least one year. Duck embryo cell culture appeared to be an attractive material for preparing vaccine because it was of a nonmammalian source and because of the relative freedom of ducks from disease.



Author Affiliations

From the Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa (Drs. Buynak and Hilleman), and the Department of Pediatrics, School of Medicine, University of Pennsylvania, Philadelphia (Drs. Weibel and Stokes).


Footnotes

Reprint requests to Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa 19486 (Dr. Buynak).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combined Live Rubella-Mumps Virus Vaccine Findings in Clinical-Laboratory Studies
Weibel et al.
JAMA 1971;216:983-986.
ABSTRACT  

Failure to Transmit Rubella Virus Vaccine: A Close-Contact Study in Adults
Halstead and Diwan
JAMA 1971;215:634-636.
ABSTRACT  

Immunologic Response, Virus Excretion, and Joint Reactions with Rubella Vaccine: A Study of Adolescent Girls and Young Women Given Live Attenuated Virus Vaccine (HPV-77:DE-5)
LERMAN et al.
ANN INTERN MED 1971;74:67-73.
ABSTRACT  

Recent Advances in Immunization Against Viral Diseases
STOKES
ANN INTERN MED 1970;73:829-840.
ABSTRACT  

Frequency of Arthralgia in Women Receiving One of Three Rubella Vaccines
Monto et al.
Arch Intern Med 1970;126:635-639.
ABSTRACT  

Evaluation of Three Rubella Vaccines in Adult Women
Halstead et al.
JAMA 1970;211:991-995.
ABSTRACT  

Attenuated Rubella Viruses: Laboratory and Clinical Characteristics
Meyer et al.
Arch Pediatr Adolesc Med 1969;118:155-165.
ABSTRACT  

Live Attenuated Rubella Virus Vaccines: Experiences with Duck Embryo Cell Preparations
Hilleman et al.
Arch Pediatr Adolesc Med 1969;118:166-171.
ABSTRACT  

Rubella Virus Vaccine (HPV-77-DE 5) Antigenic and Protective Efficacy in a Community Trial
McCollum et al.
Arch Pediatr Adolesc Med 1969;118:186-189.
ABSTRACT  

Comparative Studies of Rubella Vaccines
Karchmer et al.
Arch Pediatr Adolesc Med 1969;118:197-202.
ABSTRACT  

Rubella Vaccine Evaluation in a Public School System
Schiff et al.
Arch Pediatr Adolesc Med 1969;118:203-208.
ABSTRACT  

Transient Arthritis After Rubella Vaccination
Cooper et al.
Arch Pediatr Adolesc Med 1969;118:218-225.
ABSTRACT  

Live Rubella Vaccines in Adults and Children: HPV-77 and Merck-Benoit Strains
Weibel et al.
Arch Pediatr Adolesc Med 1969;118:226-229.
ABSTRACT  

Experimental Rubella Studies: I. Clinical and Laboratory Features of Infection Caused by the Brown Strain Rubella Virus; II. Artificial Challenge Studies of Adult Rubella Vaccinees
Schiff et al.
Arch Pediatr Adolesc Med 1969;118:269-274.
ABSTRACT  

Review of Studies With Inactivated Rubella Virus
Beck
Arch Pediatr Adolesc Med 1969;118:328-333.
ABSTRACT  

Laboratory Testing in Rubella Vaccine Control
Hopps et al.
Arch Pediatr Adolesc Med 1969;118:338-346.
ABSTRACT  

Production and Testing of Rubella Virus Vaccine: Prepared on WI-38 Cell Cultures
Tint and Rosanoff
Arch Pediatr Adolesc Med 1969;118:367-371.
ABSTRACT  

Combined Live Measles, Mumps, and Rubella Virus Vaccines
Buynak et al.
JAMA 1969;207:2259-2262.
ABSTRACT  

Live Attenuated Rubella Virus Vaccines Prepared in Duck Embryo Cell Culture: II. Clinical Tests in Families and in an Institution
Weibel et al.
JAMA 1968;205:554-558.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.